Major landmark tonight in the long fight against cancer and big tobacco
On January 1, 1971, at 11:59 PM, almost exactly 40 years ago to the minute, Phillip Morris USA ran an extremely brief ad on US television for its Virginia Slims cigarettes, showing little more than the famous slogan, You've Come A Long Way, Baby.
It was the last promotional TV spot for cigarettes ever to run on American television.
This was achieved thanks to a young lawyer named John Banzhaf, who used an obscure 'fairness doctrine' established by Congress that allowed opposing viewpoints to run on the airwaves to sue a particular TV station to allow spots to run that showcased the health risks of cigarettes. Despite teams of big tobacco lawyers and years of litigation, Banzhof won. Big tobacco withdraw their TV spots, rather than face opposing viewpoints.
Source: Mukherjee, Siddhartha. "The Emperor of All Maladies". 2010. Scribner; New York.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
